Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alissa Nguyen"'
Autor:
Anca Chelariu-Raicu, Sarina A. Piha-Paul, Mariana Chavez-MacGregor, Jason Johnson, Raymond Sawaya, Mary Frances McAleer, Alissa Nguyen, Audrey Hartnett, Apostolia M. Tsimberidou, Funda Meric-Bernstam, Ecaterina E. Dumbrava
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 3, Pp 158-161 (2023)
Poly (adenosine diphosphate-ribose) polymerase inhibitors (PARP)i are emerging as standard oncology treatments in various tumor types. The indications will expand as PARPi are being investigated in various breast cancer subtypes. Currently, except fo
Externí odkaz:
https://doaj.org/article/545f86fe16e24768a57c93689e01ab61
Autor:
Raymond Sawaya, John de Groot, Hussein Abdul-Hassan Tawbi, Tina Marie Briere, Jing Li, Jeffrey S. Weinberg, Nandita Guha-Thakurta, Ecaterina Ileana Dumbrava, Elizabeth M. Burton, Sujit S. Prabhu, Alissa Nguyen, Yan Wang, Frederick F. Lang, Barbara O’Brien, Rashmi Krishna Murthy, Wendy Austin, Donald F. Schomer, Caroline Chung, Mark Wozny, Denise J. Zaebst, Mary Frances McAleer, Sherise D. Ferguson, Suzanne E. Davis, W. K. Alfred Yung, Jordi Rodon, Ganesh Rao, Isabella C. Glitza, Debra Nana Yeboa, Dima Suki, Michael Davies, David Vining, Amy B. Heimberger
Publikováno v:
Neuro-oncology Advances
BACKGROUND: ~30% cancer patients develop brain metastases (BM), reflected by ~1600 BM patients treated at MD Anderson Cancer Center annually. With advances in systemic therapy and extracranial disease control, BM is a growing challenge. Multi-discipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04dcb05cd908bf00ec7367b5be1511f5
https://doi.org/10.1093/noajnl/vdz014.069
https://doi.org/10.1093/noajnl/vdz014.069